Current treatments against mucormycosis and future directions
Authors:
Open Access
- 13 October 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 18 (10) , e1010858
Abstract
Mucormycosis (previously called zygomycosis) is a serious but rare fungal infection caused by a group of fungi belonging to the order Mucorales. These molds exist throughout the environment and generally do not cause serious problems in humans. Mucormycosis mainly affects individuals who are immunocompromised. The clinical manifestations of mucormycosis are wide-ranging; they include sinusitis (pansinusitis, rhino-orbital, or rhino-cerebral) as well as cutaneous, gastrointestinal, pulmonary, and disseminate infections. Many uncertainties remain regarding how to control these infections despite the recent addition of triazoles to the antifungal arsenal for treating this infection. Currently, lipid formulations of amphotericin B have become the standard treatment for mucormycosis due to their efficiency. Moreover, a growing body of data supports the need for surgical excision of infected and/or necrosed tissue whenever practical. In this mini review, the current status of treatment options for mucormycosis and recent studies of novel therapeutic options will be presented.Keywords
Funding Information
- Max and Minnie Tomerlin Voelcker Fund
- Mindful Foundation
- UTSA RISE-PhD program (NIGMS RISE GM60655)
This publication has 33 references indexed in Scilit:
- In Vitro and In Vivo Activities of Posaconazole and Amphotericin B in a Murine Invasive Infection by Mucor circinelloides: Poor Efficacy of PosaconazoleAntimicrobial Agents and Chemotherapy, 2012
- Combination Therapy for Mucormycosis: Why, What, and How?Clinical Infectious Diseases, 2012
- Early Clinical and Laboratory Diagnosis of Invasive Pulmonary, Extrapulmonary, and Disseminated Mucormycosis (Zygomycosis)Clinical Infectious Diseases, 2012
- A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)Clinical Infectious Diseases, 2012
- Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia SpeciesClinical Microbiology Reviews, 2011
- Genomic Analysis of the Basal Lineage Fungus Rhizopus oryzae Reveals a Whole-Genome DuplicationPLOS Genetics, 2009
- Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral MucormycosisClinical Infectious Diseases, 2008
- Posaconazole: A Broad-Spectrum Triazole Antifungal AgentClinical Infectious Diseases, 2007
- Posaconazole as Salvage Therapy for ZygomycosisAntimicrobial Agents and Chemotherapy, 2006
- Zygomycosis: Reemergence of an Old PathogenClinical Infectious Diseases, 2004